Q2 2025 13F Holders as of 6/30/2025
-
Type / Class
-
Equity / Common Stock, $0.0001 par value
-
Shares outstanding
-
29.7M
-
Number of holders
-
10
-
Total 13F shares, excl. options
-
43.2K
-
Shares change
-
-38.8K
-
Total reported value, excl. options
-
$208K
-
Value change
-
-$197K
-
Number of buys
-
3
-
Number of sells
-
-7
-
Price
-
$4.77
Significant Holders of Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX) as of Q2 2025
14 filings reported holding DWTX - Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value as of Q2 2025.
Dogwood Therapeutics, Inc. - Common Stock, $0.0001 par value (DWTX) has 10 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 43.2K shares
of 29.7M outstanding shares and own 0.15% of the company stock.
Largest 10 shareholders include MORGAN STANLEY (17.5K shares), GEODE CAPITAL MANAGEMENT, LLC (12.8K shares), VANGUARD GROUP INC (11.8K shares), Tower Research Capital LLC (TRC) (792 shares), SBI Securities Co., Ltd. (153 shares), Activest Wealth Management (120 shares), BlackRock, Inc. (30 shares), RAYMOND JAMES FINANCIAL INC (24 shares), BANK OF AMERICA CORP /DE/ (17 shares), and GROUP ONE TRADING LLC (9 shares).
This table shows the top 10 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.